216 related articles for article (PubMed ID: 33562877)
21. Radiolabeling and Quantitative In Vivo SPECT/CT Imaging Study of Liposomes Using the Novel Iminothiolane-
Varga Z; Szigyártó IC; Gyurkó I; Dóczi R; Horváth I; Máthé D; Szigeti K
Contrast Media Mol Imaging; 2017; 2017():4693417. PubMed ID: 29097923
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m labeled Ibuprofen: Development and biological evaluation using sterile inflammation induced animal models.
Khan NU; Naqvi SAR; Sohail H; Roohi S; Jamal MA
Mol Biol Rep; 2019 Jun; 46(3):3093-3100. PubMed ID: 30929160
[TBL] [Abstract][Full Text] [Related]
23. Preparation and biological evaluation of (99m)Tc-ropinirole as a novel radiopharmaceutical for brain imaging.
Motaleb MA; Ibrahem IT; Ayoub VR; Geneidi AS
J Labelled Comp Radiopharm; 2016 Apr; 59(4):147-52. PubMed ID: 26913705
[TBL] [Abstract][Full Text] [Related]
24. Development of
Rainone P; Riva B; Belloli S; Sudati F; Ripamonti M; Verderio P; Colombo M; Colzani B; Gilardi MC; Moresco RM; Prosperi D
Int J Nanomedicine; 2017; 12():3447-3461. PubMed ID: 28496321
[TBL] [Abstract][Full Text] [Related]
25. (99m)Tc-labeling of ciprofloxacin and nitrofuryl thiosemicarbazone using fac-[(99m)Tc(CO)3(H2O)3] core: evaluation of their efficacy as infection imaging agents.
Halder KK; Nayak DK; Baishya R; Sarkar BR; Sinha S; Ganguly S; Debnath MC
Metallomics; 2011 Oct; 3(10):1041-8. PubMed ID: 21833405
[TBL] [Abstract][Full Text] [Related]
26. Harnessing the Maltodextrin Transport Mechanism for Targeted Bacterial Imaging: Structural Requirements for Improved in vivo Stability in Tracer Design.
Axer A; Hermann S; Kehr G; Clases D; Karst U; Fischer-Riepe L; Roth J; Fobker M; Schäfers M; Gilmour R; Faust A
ChemMedChem; 2018 Feb; 13(3):241-250. PubMed ID: 29195027
[TBL] [Abstract][Full Text] [Related]
27. New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification.
Emrarian I; Sadeghzadeh N; Abedi SM; Abediankenari S
Chem Biol Drug Des; 2018 Jan; 91(1):304-313. PubMed ID: 28816013
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of
Zhang X; Hu F; Liu C; Yin L; Zhang Y; Zhang Y; Lan X
Contrast Media Mol Imaging; 2018; 2018():7832805. PubMed ID: 29853809
[TBL] [Abstract][Full Text] [Related]
29. A Novel Method for the Synthesis of (99m)Tc-Ofloxacin Kits Using D-Penicillamine as Coligand and Their Application as Infection Imaging Agent.
Abdul Qadir M; Shahzad S; Rasheed R; Ahmed M; Anwar S; Kiran Shahzadi S
Biomed Res Int; 2015; 2015():502680. PubMed ID: 26090412
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
31. [
Mazaheri Tehrani M; Erfani M; Amirmozafari N
Chem Biol Drug Des; 2021 Apr; 97(4):904-913. PubMed ID: 33326679
[TBL] [Abstract][Full Text] [Related]
32. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
[TBL] [Abstract][Full Text] [Related]
33. Microbial targeting of 99mTc-labeled recombinant human beta-defensin-3 in an animal model of infection: a feasibility pilot study.
Liberatore M; Pala A; Scaccianoce S; Anagnostou C; Di Tondo U; Calandri E; D'Elia P; Gross MD; Rubello D
J Nucl Med; 2009 May; 50(5):823-6. PubMed ID: 19372483
[TBL] [Abstract][Full Text] [Related]
34. Molecular imaging of fibrosis using a novel collagen-binding peptide labelled with
Zheng L; Ding X; Liu K; Feng S; Tang B; Li Q; Huang D; Yang S
Amino Acids; 2017 Jan; 49(1):89-101. PubMed ID: 27633720
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of
Rizvi SFA; Tariq S; Mehdi M; Hassan AJ
Chem Biol Drug Des; 2019 Jun; 93(6):1166-1174. PubMed ID: 30370631
[TBL] [Abstract][Full Text] [Related]
36. Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria.
Coya JM; Fraile-Ágreda V; de Tapia L; García-Fojeda B; Sáenz A; Bengoechea JA; Kronqvist N; Johansson J; Casals C
Front Immunol; 2022; 13():927017. PubMed ID: 36159837
[TBL] [Abstract][Full Text] [Related]
37. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
38. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
[TBL] [Abstract][Full Text] [Related]
39. Clinical translation of a PSMA inhibitor for
Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
[TBL] [Abstract][Full Text] [Related]
40. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
